Is BPC-157 Legal in Tennessee?
HealthRX.com
No federal rule clearly makes BPC-157 legal to compound
From the public record
FDA product listings naming BPC-157
The FDA NDC Directory holds 20 listings naming BPC-157 from 16 firms: 20 bulk ingredient listings and 0 finished product listings, 0 under an FDA-approved application. A listing is a registration by a firm, not an FDA approval.
| Measure | Value | Note |
|---|---|---|
| Listings naming BPC-157 | 20 | |
| Bulk ingredient listings | 20 | raw material registrations, not finished medicines |
| Of those, bulk ingredient for human prescription compounding | 8 | |
| Finished product listings | 0 | |
| Listings under an FDA-approved application | 0 | |
| Firms with a listing | 16 |
How this was calculated
Searched ingredient and product names in the NDC Directory download for the exact name variants, then counted listings by FDA marketing category and by listing firm.
Current NDC Directory listings whose ingredient or product name contains BPC 157 or BPC-157
Firms submit listings themselves. A listing does not mean FDA has reviewed the substance for safety or effectiveness, or that it may lawfully be compounded.
From the public record
FDA drug recalls naming BPC-157
FDA enforcement reports list 6 drug recall entries naming BPC-157 from 2019 to 2025-10-15. 6 of them are for compounded or other unlisted products and 0 for products FDA lists under a label. The most common stated reason was lack of sterility assurance (6 of 6).
| Measure | Value | Note |
|---|---|---|
| Recall entries on record | 6 | |
| For products FDA lists under an approved or registered label | 0 | |
| For compounded or other unlisted products | 6 | matched by the name in the product description |
| Class I (most serious) | 0 | |
| Class II | 6 | |
| Class III | 0 | |
| Most recent recall reported | 2025-10-15 | |
| Most common stated reason | lack of sterility assurance | 6 of 6 entries |
How this was calculated
Counted enforcement report entries matched by FDA's listed active substance, or by the name in the product description where FDA lists none. Reasons were grouped by keywords in FDA's stated reason.
Recalls whose product description names BPC-157, including compounded and multi-ingredient products
Each recall covers specific lots from one firm and is not a statement about every product with this ingredient. One event can appear as several entries, one per product.
From the public record
Registered clinical studies of BPC-157
ClinicalTrials.gov lists 4 registered studies that name BPC-157 as an intervention as of 2026-11-11. Of these, 1 are recruiting, 1 are completed and 0 are phase 3 studies.
| Measure | Value |
|---|---|
| Registered studies | 4 |
| Recruiting now | 1 |
| Not yet recruiting | 1 |
| Completed | 1 |
| Terminated, withdrawn or suspended | 0 |
| Phase 3 (including phase 2/3) | 0 |
| Phase 2 (including phase 1/2) | 1 |
| Phase 1 | 2 |
How this was calculated
Searched the ClinicalTrials.gov intervention field for the name, downloaded every matching record and counted by overall status and phase. Combined phases are counted under the higher phase. Phase not applicable covers observational, device and behavioural studies.
Studies whose intervention field matches BPC 157 or BPC-157, any condition, any country, all statuses
A registered study is not a result. Counts include studies where the drug is a comparator or background treatment, and studies that never finished or reported.
At a glance
- FDA approval / None; no approved drug contains BPC-157 [3]
- FDA bulk-substance categories / In none of the three, as of May 14, 2026 [1]
- Category 2 history / September 2023 to April 22, 2026, then withdrawn by nominators [4]
- HHS draft policy / October 28, 2026; non-binding, not an approval [2]
- Outsourcing facilities / Not on FDA's list, updated March 21, 2025 [5]
- Sport / WADA names it in S0, prohibited at all times [6]
What the federal status is
BPC-157 is not an FDA-approved drug: FDA's July 2026 review found no approved product containing it in any country it searched, and there is no US Pharmacopeia or National Formulary monograph for it [3]. It sat in FDA's category 2 of bulk substances that may present significant safety risks when compounded from September 2023 until April 22, 2026, then moved to a 'nominated but withdrawn' table after the nominating groups withdrew; the move was not a finding of safety [4]. On FDA's list for state-licensed pharmacies and physicians, updated May 14, 2026, it is in none of the three categories. Category 1 is the group FDA says it generally will not act against compounders for when conditions are met, so that policy does not cover BPC-157 [1].
What people on Reddit report
Reddit users in one thread asking whether this peptide is illegal or being banned in the US. Accounts mix guesses about motives with secondhand claims about compounding and oral forms.
FDA says not enough safety data. But I call BS. (Tin foil hat on) BPC has been around a long time. I would bet big pharma can't profit off it so they paid the FDA to shut it down. (Tin foil hat off)Read the source discussion
FDA has to be sure that safety has been proven by successful, clinical phase 3 trials. There's barely any human studies on BPC, so why should it be allowed?Read the source discussion
Questions worth asking
The draft HHS policy of October 2026
HHS filed a notice on October 28, 2026 announcing a draft enforcement-discretion policy for six peptides, BPC-157 among them [2]. HHS says it 'does not intend to take enforcement action' against a state-licensed pharmacy, federal facility or licensed physician compounding with a listed peptide while FDA's list is developed through rulemaking, if the policy's conditions are met [2]. For BPC-157 the draft conditions include the acetate form only, subcutaneous, intramuscular, oral or topical routes, a single active ingredient, a patient-specific prescription, MedWatch reporting of serious adverse events, and documentation of adequate bioavailability for oral forms [7]. The notice says the policy 'does not establish any rights for any person and is not binding on HHS or the public'. It names state-licensed pharmacies, federal facilities and licensed physicians, not outsourcing facilities [2].
The July 2026 advisory committee vote
On July 23, 2026 FDA's Pharmacy Compounding Advisory Committee voted in favor of adding BPC-157 to the pharmacy bulks list, against FDA staff's recommendation; the vote is non-binding advice [8]. FDA's reviewers had proposed against listing it, citing poor chemical characterization, limited safety and immunogenicity information, and insufficient evidence that it works for ulcerative colitis [3]. Adding a substance to the list requires formal rulemaking [7].
Tennessee state law
Tennessee's own requirements are not covered on this page, which describes only the federal position above.
Check what you know
Question 1 of 4
Score: 0 right, 0 of 4 answered
Frequently asked questions
Is BPC-157 legal in Tennessee?
Did FDA ban BPC-157?
Is BPC-157 allowed in sport?
Reader questions
What people actually ask
Short answers drawn from the sources this article cites.
Can you legally be prescribed BPC-157?
No approved prescription exists because BPC-157 is not FDA-approved. A draft HHS policy from October 28, 2026 says HHS does not intend enforcement action against a licensed physician compounding it if the policy's conditions are met, including a patient-specific prescription and subcutaneous, intramuscular, oral or topical routes. The draft is non-binding and is not an approval.
Where can I legally get BPC-157?
No legal source for BPC-157 is established. It is not FDA-approved, and it is not on FDA's list for outsourcing facilities, updated March 21, 2025. The draft HHS policy covers state-licensed pharmacies, federal facilities and licensed physicians, not outsourcing facilities, and it is not final.
Is BPC-157 on the banned substance list?
Yes. WADA names BPC-157 in S0, non-approved substances, which are prohibited at all times, in and out of competition. The 2026 List has been in force since January 1, 2026.
References
Show all 9 referencesHide references
- U.S. Food and Drug Administration.
- Official web page.
- U.S. Food and Drug Administration.
- Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks | FDA.
- U.S. Food and Drug Administration.
- World Anti-Doping Agency.
- Official web page.
- U.S. Food and Drug Administration.
- Reddit participants. What is the status of BPC-157 in the US? Is it illegal yet? Are they still trying to ban it? (r/bpc_157). Accessed 2026-11-11.